Slow and steady may win the race, but group CI has a long way to go before it can contemplate overtaking other products in the group market, let alone individual CI, explains Edward Murray Click here to download pdf (PDF, 2.4MB)
According to figures from the Swiss Re Group Watch 2008 report, annual market premiums for group risk have risen by 5.2% from £1.51bn in 2006 and now stand at £1.59bn for 2007. Looking specifically at the group critical illness (CI) market, in force market premiums totalled £37.2m and were up 7% on the £34.7m for 2006. The group CI market is therefore still a relatively small player in the context of other group benefits available. However, although it is coming off a very low base, the fact that since 2003 annual premium income is up by 75% has to be viewed as encouraging, if not overwhe...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
